Luis Baez Diaz
Hematology & Oncology · San Juan, PRNPI 1467455535
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,273 of the $5,730 with a category attached, or 74.6%. 28 manufacturers reported payments, led by Merck at 27.1% of the total. Reporting peaked in 2019 at $2,729 and has fallen 99.6% since, to $11 in 2022. That places this record below the midpoint for hematology & oncology clinicians in PR, where the typical reported total is $10,882.
Across 229 payments — averaging $25.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$2K
- Johnson & Johnson$479
- Eli Lilly Export S.A. Puerto Rico Branch$436
- E.r. Squibb & Sons, L.L.C.$377
- AstraZeneca$364
- Genentech USA, Inc.$315
- plus $2K from 22 others
Across 6 payments — averaging $3474.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$21K
What the payments were for
- Consulting fees$1,32523%
- Food & beverage$4,27375%
- Education$1322%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 14 | $1,550 |
| Johnson & Johnson | 26 | $479 |
| Eli Lilly Export S.A. Puerto Rico Branch | 23 | $436 |
| E.r. Squibb & Sons, L.L.C. | 19 | $377 |
| AstraZeneca | 20 | $364 |
| Genentech USA, Inc. | 18 | $315 |
| Novartis | 14 | $301 |
| Clovis Oncology, Inc. | 8 | $219 |
| Sanofi | 12 | $218 |
| Amgen | 11 | $186 |
| PBG Puerto Rico LLC | 8 | $152 |
| Eisai Inc. | 8 | $146 |
| AbbVie | 7 | $140 |
| Puma Biotechnology, Inc. | 8 | $139 |
| Boehringer Ingelheim | 1 | $125 |
| Exelixis Inc. | 5 | $89 |
| Sanofi-aventis U.S. LLC | 4 | $75 |
| Pfizer Pharmaceuticals LLC | 4 | $67 |
| Pfizer | 4 | $58 |
| Bristol Myers Squibb | 2 | $51 |
| Seagen Inc. | 2 | $44 |
| Bayer | 2 | $39 |
| Rigel Pharmaceuticals, Inc. | 2 | $39 |
| Taiho Oncology, Inc. | 2 | $36 |
| Gilead | 2 | $25 |
| Spectrum Pharmaceuticals Inc. | 1 | $22 |
| ADC Therapeutics America, Inc. | 1 | $22 |
| Beigene USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,730 in reported general payments places this provider in the 35th percentile of 138 hematology & oncology providers in Puerto Rico.
Other hematology & oncology in San Juan
- Alexis Cruz ChaconSan Juan$450K
- Jose Lozada CostasSan Juan$260K
- Cristian Rodriguez ArochoSan Juan$227K
- Noridza Rivera RodriguezSan Juan$177K
- Mirelis AcostaSan Juan$154K
- Luis Baez VallecilloSan Juan$107K
- Edgardo Santiago-GuzmanSan Juan$79K
- Adelba Torres-LopezSan Juan$73K
- Karla Feliciano SalvaSan Juan$44K
- Luis Delgado MateuSan Juan$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.